Introduction
Focal hypertrophy of multiple nerve roots can be observed in several unrelated conditions, such as neurofibromatosis and multiple sclerosis, whereas symmetric spinal root enlargement can occur in chronic inflammatory polyradiculoneuropathies [1] . Focal nerve hypertrophy is commonly secondary to either neoplastic growth of the Schwann cells or of perineurial elements, or to abnormal enlargement of the nerve trunks due to Schwann cell proliferation and hyperplasia. Asymmetric hypertrophy of either cranial or spinal nerves was described in demyelinating hereditary motor and sensory neuropathies (HMSN), both in Charcot-MarieTooth 1 [CMT1, 2-6] and Dejerine Sottas syndrome (DSS; 7-9) patients. This feature is consistent with abnormally redundant "onion bulb" formation by the Schwann cells due to ongoing de/remyelination. The unusual occurrence of symmetrical enlargement of multiple cranial nerves and multifocal involvement of both spinal and caudal nerves is here reported in a patient affected with a severe form of DSS associated with a missense mutation of the Myelin Protein Zero (MPZ/P0) gene, which codes for the major protein of peripheral myelin.
s Abstract In a patient affected with a slowly progressive, severe form of Dejerine-Sottas syndrome, symmetric enlargement of cranial nerves and focal hypertrophy of cervical and caudal roots were detected following MRI. Neuropathological features of the sural nerve disclosed a dramatic loss of myelinated fibres, with skewed-to-theleft, unimodal distribution of the few residual fibres, consistent with the diagnosis of congenital hypomyelination neuropathy. Genetic analysis revealed this condition to be associated with a heterozygous G to A transition at codon 167 in the exon 4 of the MPZ/P0 gene causing a Gly138Arg substitution in the transmembrane domain of the mature MPZ/P0 protein. Focal enlargement of the nerve trunks in demyelinating, hereditary motor and sensory neuropathies (HMSN) was previously reported in both asymptomatic and symptomatic cases with root compression, but peculiar to this case is the diffuse involvement of both cranial and spinal nerves. We believe that the relevance of nerve trunk hypertrophy in HMSN is probably underevaluated: therefore MRI investigation of the head and spine should be included in the diagnostic study of selected HMSN patients. Molecular analysis of peripheral myelin genes will help to rule out misdiagnosed cases.
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The patient is a computer operator born in Kenya, Africa. Both parents were native from Kenya; his family record is not available. He remembers delayed motor acquisition and walking; when 6 years old he needed a crutch to stand and walk. Then progressive impairment of his motor abilities occurred along with ataxia. When he was 12 years old distal muscle atrophy, severe kyphoscoliosis and the onset of peripheral sensory impairment were reported. By the age of 17 he developed cranial nerve involvement (diplopia, motor and sensory impairment of the fifth nerve, mild hypoacusis and rotatory nystagmus); he was also wheel-chair bound. He was referred to us for evaluation at age 22 years with the putative diagnosis of neurofibromatosis type 2, put forward following MRI investigations of the head and whole spine, which revealed the presence of bilateral tumour-like growths of cranial nerves, including the acoustic nerve, and involvement of several spinal roots at different cord levels. Owing to the severe motor impairment of the four limbs, he could not walk even with bilateral support, nor could he stand unsupported because of the severe foot deformities. Other main clinical features were disto-proximal amyotrophy with "en griffe" hands, hypoplasic feet, severe kyphoscoliosis of the whole spine, bilateral genu recurvatum; deep reflexes could not be elicited; there was also severe hypotonia of the four limbs with hypopallesthesia; antigravitary strength of the lower limbs could not be tested. Spontaneous fasciculations could be seen. Cranial nerve examination confirmed the diplopia due to bilateral impairment of both third cranial nerves, with proptosis, exophoria of the left eye, the presence of motor and sensory impairment of fifth nerve, and mild bilateral hypoacusis associated with rotatory nystagmus.
Electromyography revealed features of denervation; following voluntary activity bi-phasic motor unit potentials of increased amplitude were detected. Electroneurography of both median nerves showed markedly decreased amplitude of compound action motor potentials, increased distal latency and very low motor nerve conducton velocity; sensory action potentials could not be elicited. Increased latency and impairment of the peripheral conduction was observed following brainstem acoustic evoked responses bilaterally (Table 1) .Auditory function testing disclosed mild hypoacusia, mainly of the high tones.
Head magnetic resonance imaging (MRI) showed focal, bilateral enlargements of most cranial nerves (III,V, VI,VII,VIII, IX, X, XI); the largest growth affects the fifth nerve, at the Gasserion ganglion and the origin of its main branches. Two hypertrophic roots of the cervical tract of the spine were seen. Examination of the lumbar sacral tract revealed enlarged spinal canal with posterior scallopping of the vertebral bodies; all caudal roots were enlarged. Both cranial and spinal roots did not enhanced significantly following gadolinium injection (Fig. 1) .
A sural nerve biopsy revealed features of severe hypomyelination with markedly reactive Schwann cells. Total transverse fascicular area was increased 3-fold (3.44 mm 2 ); there was a dramatic lack of myelinated fibres (fibre density 130 ff/mm 2 ), with unimodal histogram, fibre size ranging between 2-8 µm. There was marked Schwann cell hyperplasia, with complex onion bulbs made of multilayered processes of Schwann cell cytoplasm. There was no evidence of active demyelination, nor features of remyelination (Fig. 2) .
Molecular genetic analysis was carried out as previously described [10] . The 1.5 megabase, common duplication at chromosome 17p11.2 was excluded by PulseField Gel Electrophoresis. The coding regions of MPZ/P0 and of the genes coding the peripheral myelin protein 22 (PMP22) and the early growth response 2 (EGR2) transcription factor were analysed by automated direct sequencing. We detected a heterozygous G to A transition at codon 167 of exon 4 of MPZ/P0 (GGG ¡ AGG), which predicts a glycine to arginine substitution. In the mature protein, which is formed after removal of the first 29 aminoacids, the mutation corresponds to a Gly138Arg heterozygous substitution in the transmembrane domain of MPZp.
Discussion
Clinical features as well as neurophysiological and neuropathological findings of this patient are consistent with the diagnosis of a severe form of DSS, namely congenital hypomyelination neuropathy (CHN). His condition worsened slowly along the years, and the patient 
